Ocugen, Inc.
OCGN
$1.39
-$0.07-4.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -125.26% | 54.23% | 20.33% | 46.06% | -45.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -125.26% | 54.23% | 20.33% | 46.06% | -45.78% |
| Cost of Revenue | 28.70% | 37.51% | -5.62% | 39.60% | 6.57% |
| Gross Profit | -44.33% | -34.78% | 9.43% | -38.47% | -18.15% |
| SG&A Expenses | -2.87% | 31.02% | -11.99% | 0.77% | 22.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -8,676.92% | 132,000.00% | -- | -- | -- |
| Total Operating Expenses | 7.33% | 43.85% | -8.57% | 20.80% | 12.81% |
| Operating Income | -14.66% | -42.96% | 10.71% | -18.70% | -19.97% |
| Income Before Tax | -27.56% | -54.60% | 3.54% | -28.73% | -26.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.56% | -54.60% | 3.54% | -28.73% | -26.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.56% | -54.60% | 3.54% | -28.73% | -26.53% |
| EBIT | -14.66% | -42.96% | 10.71% | -18.70% | -19.97% |
| EBITDA | -15.33% | -42.38% | 13.47% | -12.92% | -16.60% |
| EPS Basic | -18.87% | -41.63% | 14.84% | -13.61% | -11.71% |
| Normalized Basic EPS | -18.79% | -41.58% | 15.09% | -13.45% | -11.61% |
| EPS Diluted | -18.87% | -41.63% | 14.84% | -13.61% | -11.71% |
| Normalized Diluted EPS | -18.79% | -41.58% | 15.09% | -13.45% | -11.61% |
| Average Basic Shares Outstanding | 7.36% | 9.29% | 13.49% | 13.51% | 13.36% |
| Average Diluted Shares Outstanding | 7.36% | 9.29% | 13.49% | 13.51% | 13.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |